Market Overview
The global Drugs of Abuse Test Kit market was valued at USD 467 million in 2024 and is projected to reach USD 843 million by 2031, exhibiting a CAGR of 9.0% during the forecast period.
USD 467 million in 2024
2032 USD 843 million by 2031
of 9.0%
Urine Test Kits remain the most widely adopted format due to their costeffectiveness and established reliability for workplace testing, while Saliva Test Kits are gaining traction for their non-invasive nature and rapid results in pointof-care settings.
Urine Test Kits
Saliva Test Kits
Hair Test Kits
By Application
Workplace Testing
Criminal Justice Systems
Rehabilitation Centers
Home Testing Kits
The Workplace Testing segment drives the largest volume due to corporate wellness programs and pre-employment screening mandates. Home Testing Kits show the highest growth rate as privacy-conscious consumers seek discreet monitoring solutions, while Rehabilitation Centers demand robust testing with clinical-grade accuracy.
Our Key Players
Abbott Laboratories (USA)
Siemens Healthineers (Germany)
Thermo Fisher Scientific Inc. (USA)
Roche Diagnostics (Switzerland)
Quest Diagnostics (USA)
Samsung Electronics (South Korea)
Drägerwerk (Germany)
https://www.24lifesciences.com
